Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Moderna’s Bancel Dismisses GSK And Sanofi Challenge In mRNA Vaccines

New Entrants Will Find “It’s Much Harder Than They Think”

Executive Summary

Under pressure to show Moderna can grow the company’s mRNA vaccines portfolio beyond COVID-19, CEO Stéphane Bancel has talked down his rivals in the field.

You may also be interested in...



Moderna Looks To Catch Up In COVID-19 For Kids, While Still Branching Out In Other Areas

The company hopes to expand Spikevax’s reach beyond the current approved population while also looking to take the lead in mRNA vaccines in other diseases.

Coronavirus Update: AbbVie Jumps Into Antiviral Research With Scripps Pact

AbbVie is taking the plunge into the highly competitive area of antiviral research through a new alliance, while Pfizer files for US approval of an additional mRNA booster shot and a vaccines group is unhappy about planned IP waivers. 

Affimed And BioNTech Immunotherapies Among Ones To Watch At AACR

Affimed looks to build on the splash at last year’s American Association for Cancer Research meeting next month, while BioNTech aims to prove its immunotherapy capabilities with a CAR-T candidate.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC146042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel